Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clarins S&E

This article was originally published in The Rose Sheet

Executive Summary

Cosmetics division third quarter sales benefit from diversification of Clarins brand with Clarins Men skin care debut and U.S. launch of Hugo Boss Boss In Motion men's fragrance, Parisian firm reports in 1third quarter sales release Oct. 18. Consolidated sales for the quarter were up 3.4% to $204.7 mil. For the nine months, Clarins brand sales rose 1.4% to $388.6. (€1=$.97) at average exchange rates, and Thierry Mugler grew 7.1% to $115.7 mil. Azzaro sales increased 3.1% to $66.1mil., and Perfume Distribution sales were $63.4 mil., up 5.8%...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010683

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel